It’s Time to Combine Artificial Intelligence with Cardiac Imaging
Artificial intelligence, also called AI of which machine learning is a subset, is working already in millions of offices and homes. As computer users open…
Artificial intelligence, also called AI of which machine learning is a subset, is working already in millions of offices and homes. As computer users open…
One of the biggest challenges facing the NHS is the ever-growing patient waiting list for a variety of urgent and non-urgent treatments, exacerbated by numerous…
Digital health company Pilloxa is to begin ASTORIA – a single-armed and multi-centre observational clinical trial in which their digital patient-centric adherence solution will be…
Following on from our coverage of this year’s Atrial Fibrillation Awareness Week, we talk to Justin Hall, Vice President EMEA and General Manager UK of iRhythm…
With this week (16th November – 22nd November) marking the annual AF Awareness Week, there’s never been a better time to bring attention to the most common arrhythmia,…
A research programme to use AI and machine learning to predict and detect heart failure, which can be difficult to diagnose and is often unrecognized,…
A revolutionary new medical device, called EchoGo Pro, that can predict coronary artery disease – the number one cause of death globally – has been…
Ultromics, the UK-based health technology firm at the forefront of applying artificial intelligence to echocardiography, has received 510(K) clearance from the U.S. Food and Drug Administration (FDA)…
Digital healthcare company iRhythm Technologies has launched in the UK to support the identification and superior clinical diagnoses of cardiac arrhythmias such as atrial fibrillation (AF), the most…
The world’s first wireless, in-heart, microcomputer has begun its first clinical trial in the UK at Queen Elizabeth Hospital in Birmingham. Doctors hope that the…